Vast Relocated, Dantari Got $47M, and More LA Tech News

Catch up on the latest developments from the Los Angeles tech sector.

Written by Ashley Bowden
Published on Jan. 17, 2023
Vast Relocated, Dantari Got $47M, and More LA Tech News
The Vast team with Long Beach Mayor Rex Richardson.
The Vast team with Long Beach Mayor Rex Richardson. | Photo: Vast / Twitter

SoCal companies made huge leaps in progress for their tech solutions last week. From building out modern healthcare technology to streamlining operations for enterprises, check out what these West Coast innovators have been up to. This is the Built In LA Weekly Refresh.

Vast relocated to Long Beach. Aerospace company Vast is moving into an approximately 115,000-square-foot facility in the city’s Globemaster Corridor Specific Plan. The new headquarters and manufacturing space will house Vast’s growing team. By 2027, the company hopes to exceed a 700-person headcount. [L.A. Business First]

Live Data Technologies raised $5M. Live Data offers companies a data hygiene product and a database of up-to-date contact information for professionals. The Series A funding from Entrada Ventures will help the Santa Barbara-based company invest in product development and expand its team across sales, marketing and technology. [Built In LA]

LA Tech Quote of the Week

“What I’m excited about is enabling people … that thought they needed engineers or needed [a] technical background to go and build software. I want them to see that they can build the same thing without needing it.” — Nanxi Liu, Blaze.tech co-founder and co-CEO

Blaze.tech raised $3.5M. Announcing its launch alongside a round of pre-seed funding from Flybridge Capital and MaC Venture Capital, Blaze.tech is bringing its no-code web app building product to businesses everywhere. It’s advancing its platform’s artificial intelligence capabilities and expanding its team across all departments with the fresh capital. [Built In LA]

Dantari raised $47M. Biotech company Dantari exited stealth mode with a Series A round led by Westlake Village BioPartners. Dantari is developing chemotherapy treatments for cancer patients. Its lead program entered Phase 1 clinical study this year, and Dantari hopes to achieve its next clinical milestones by the second half of 2023. [LA Inno]

Hiring Now
Artera
Healthtech • Software